Literature DB >> 32648448

Epidemiology of ovarian cancer.

Patricia Gaona-Luviano1, Lourdes Adriana Medina-Gaona2, Kassandra Magaña-Pérez2.   

Abstract

Worldwide, ovarian cancer (OC) is the seventh most common type of malignant neoplasm in women and the eighth cause of mortality in them. The classification of OC is made by the possible origin of one of the three main components of the ovary: epithelium, stroma, and germinal cells. Due to this the main malignant tumors arising from the ovary are epithelial carcinoma, germ cell tumor, sex cord-stromal tumor, and Krukenberg's tumor. The most common are the epithelial carcinomas, in which the most prevalent is serous ovarian carcinoma. Nevertheless, the subtype of OC varies according to the age of appearance. The global incidence of OC has been stable during the last decades, but, it´s still a disease that has contributed to a considerable number of deaths around the world. The epidemiology of this cancer shows differences between races and countries due to several factors including genetic and economic. The detection of this cancer has been problematic as there is no screening public program for its early detection and as a consequence, most OCs are detected in an advanced stage where most of the time it has already spread to other parts different from the ovary. The purpose of this article is to present a comprehensive review of the general epidemiology, incidence rates, prevalence rates, mortality, and survival of the different types of OC worldwide and in certain regions.

Entities:  

Keywords:  Krukenberg’s tumor; Ovarian carcinoma (OC); epidemiology; germ cells tumor; incidence; mortality; sex cord stromal tumor; survival rates

Mesh:

Year:  2020        PMID: 32648448     DOI: 10.21037/cco-20-34

Source DB:  PubMed          Journal:  Chin Clin Oncol        ISSN: 2304-3865


  18 in total

1.  The value of contrast-enhanced ultrasonography in differential diagnosis of benign and malignant ovarian sex cord stromal tumors.

Authors:  Youfeng Xu; Nianyu Xue; Shengmin Zhang; Zhuo Wei
Journal:  Gland Surg       Date:  2022-06

2.  The effect of substance P and its specific antagonist (aprepitant) on the expression of MMP-2, MMP-9, VEGF, and VEGFR in ovarian cancer cells.

Authors:  Maryam Momen Razmgah; Atefeh Ghahremanloo; Hossein Javid; Abbas AlAlikhan; Amir-R Afshari; Seyed Isaac Hashemy
Journal:  Mol Biol Rep       Date:  2022-08-12       Impact factor: 2.742

3.  Letter to the editor on "Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017, parts 1-3".

Authors:  Frank Yizhao Chen; Michael Barnes; Evan Cole Lewis
Journal:  Arch Public Health       Date:  2022-07-19

4.  Regulation of PTEN and ovarian cancer progression by an E3 ubiquitin ligase RBCK1.

Authors:  Guanghui Wang; Zi Zhuang; Siyuan Shen; Fan Yang; Zhiyuan Jiang; Ziping Liu; Tianshi Wang; Lei Hua
Journal:  Hum Cell       Date:  2022-02-16       Impact factor: 4.374

5.  Differential and divergent activity of insulin-like growth factor binding protein 6 in platinum-sensitive versus platinum-resistant high-grade serous ovarian carcinoma cell lines.

Authors:  Annamaria Piscazzi; Valentina Condelli; Fabiana Crispo; Anna Rita Daniela Coda; Giovanni Calice; Giuseppina Bruno; Santina Venuto; Daniele Tibullo; Guido Giordano; Michele Pietrafesa; Arcangelo Liso; Matteo Landriscina
Journal:  Oncol Lett       Date:  2022-04-21       Impact factor: 2.967

6.  Identification and clinical significance of somatic oncogenic mutations in epithelial ovarian cancer.

Authors:  Takafumi Watanabe; Hideaki Nanamiya; Yuta Endo; Manabu Kojima; Shinji Nomura; Shigenori Furukawa; Shu Soeda; Hirosumi Tamura; Masae Ryufuku; Daisuke Tanaka; Takao Isogai; Jun-Ichi Imai; Shinya Watanabe; Keiya Fujimori
Journal:  J Ovarian Res       Date:  2021-10-06       Impact factor: 4.234

Review 7.  Pyroptosis: A Developing Foreland of Ovarian Cancer Treatment.

Authors:  Tianyi Liu; Min Hou; Manyu Li; Cheng Qiu; Lin Cheng; Tianyu Zhu; Jinfeng Qu; Lanyu Li
Journal:  Front Oncol       Date:  2022-02-07       Impact factor: 6.244

8.  Pre-diagnosis Dietary One-Carbon Metabolism Micronutrients Consumption and Ovarian Cancer Survival: A Prospective Cohort Study.

Authors:  He-Li Xu; Ting-Ting Gong; Fang-Hua Liu; Yi-Fan Wei; Hong-Yu Chen; Shi Yan; Yu-Hong Zhao; Song Gao; Yi-Sheng Jiao; Qi-Jun Wu
Journal:  Front Nutr       Date:  2022-04-15

9.  Study on the mechanism of Danshen-Guizhi drug pair in the treatment of ovarian cancer based on network pharmacology and in vitro experiment.

Authors:  Chongzhen Qin; Menglin Wu; Xinru Wang; Wenda Zhang; Guangzhao Qi; Na-Yi Wu; Xiaoting Liu; Yaoyao Lu; Jingmin Zhang; Yuna Chai
Journal:  PeerJ       Date:  2022-04-06       Impact factor: 2.984

10.  Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients.

Authors:  Jun Li; Sile Han; Cuiyun Zhang; Yanlin Luo; Li Wang; Ping Wang; Yi Wang; Qingxin Xia; Xiaoyan Wang; Bing Wei; Jie Ma; Hongle Li; Yongjun Guo
Journal:  Front Oncol       Date:  2021-05-11       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.